Gonzalez, I M <br/><br/>
Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.  [electronic resource] 

 -  Vaccine  Mar 2000 
 - 1763-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/s0264-410x(99)00527-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Viral--blood<br/>Antibody Formation--drug effects<br/>Dose-Response Relationship, Immunologic<br/>Drug Administration Schedule<br/>Female<br/>HN Protein<br/>Humans<br/>Immunity, Mucosal--drug effects<br/>Immunoglobulin A--blood<br/>Immunoglobulin G--blood<br/>Male<br/>Middle Aged<br/>Nasal Mucosa--immunology<br/>Regression Analysis<br/>Respiratory Syncytial Virus, Human--immunology<br/>Vaccines, Attenuated--administration & dosage<br/>Viral Envelope Proteins--administration & dosage<br/>Viral Proteins--administration & dosage<br/>Viral Vaccines--administration & dosage